Insmed | INSM - Capitaux Propres Et Réserves

Prix De L'Action
134.38
Variation Quotidienne
-0.56 -0.42%
Mensuellement
-12.35%
Annuel
86.64%
Q2 Prévisions
132.28




Capitaux Propres Et Réserves Changement Date
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Cytokinetics USD -659.62M 138.5M 2025-12
DBV Technologies USD 52.85M 33.37M 2025-09
Gilead Sciences USD 22.62B 1.16B 2025-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
Insmed USD 738.98M 206.6M 2025-12
Novartis USD 46.13B 1.8B 2025-12
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12